DIRECTED BIOTICS - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Image for trademark with serial number 88755639
Serial Number
88755639
Word Mark
DIRECTED BIOTICS
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2020-10-20
Filing Date
2020-01-11
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
SCLEIDOROVICH, JOANNA
Statements
Goods and Services
Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Design and development of biological RNA-based therapeutic agents for the prevention and treatment of infectious diseases in plants and animals for use in pharmaceuticals, biotechnology, and medical and diagnostic applications; Research and development of biopharmaceutical compounds; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit mosquito populations; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target pathogen genes in plants and animals; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit vector-borne diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit aquaculture-related diseases; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit mosquito populations; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce eukaryotic-like mRNA; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce that produce commercial compounds; Research and development services, namely, RNA-based systems for yield management in plants; ; Research and development services, namely, plant transformation, plant transformation, bacterial-mediated transient eukaryotic cell transformation; Bioinformatic services, namely, rational design of novel pharmaceuticals, therapeutics and biologics
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-01-16
Primary Code
042
Correspondences
Name
DAVID S. KERR
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2020-01-15NEW APPLICATION ENTERED IN TRAM
2020-01-16NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-03-30ASSIGNED TO EXAMINER
2020-04-08NON-FINAL ACTION WRITTEN
2020-04-08NON-FINAL ACTION E-MAILED
2020-04-08NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-10-20ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
2020-10-20ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND